Is MDCG 2022-14 the ultimate solution to solve all the challenges of the MDR transition?

MDCG 2022-14 is one of the latest guidance documents and covers the “Transition to the MDR and IVDR”. It focuses on “Notified body capacity and availability of medical devices and IVDs” and targets one of the most significant issues in the current transition time. This session will highlight those elements of MDCG 2022-14 that will significantly free up resources and provide you with insight into how TÜV SÜD approaches the new guidance.

Date and time: Monday, 24 October 2022, 6:00 pm (CEST/ 12.00 pm (EDT)

Your speakers: Martin Witte, Senior Director Strategic Business Development


Register for free »